These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38931228)

  • 1. Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy.
    Zhang Y; Zhan L; Zhang L; Shi Q; Li L
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched-chain amino acid enriched supplements as therapy for liver disease.
    Charlton M
    J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched chain amino acid therapy in liver disease.
    Maddrey WC
    J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.
    Konstantis G; Pourzitaki C; Chourdakis M; Kitsikidou E; Germanidis G
    Clin Nutr; 2022 Jun; 41(6):1171-1190. PubMed ID: 35500317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism.
    Ferguson D; Eichler SJ; Yiew NKH; Colca JR; Cho K; Patti GJ; Shew TM; Lutkewitte AJ; Mukherjee S; McCommis KS; Niemi NM; Finck BN
    Mol Metab; 2023 Apr; 70():101694. PubMed ID: 36801448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
    Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
    Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
    Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases.
    Holeček M
    Physiol Res; 2021 Jul; 70(3):293-305. PubMed ID: 33982576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
    Holecek M
    Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
    Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
    Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
    Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
    Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
    EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.
    Maki H; Yamanaka-Okumura H; Katayama T; Ozawa Y; Hosoda A; Kurata N; Amemiya F
    Clin Nutr ESPEN; 2019 Apr; 30():138-144. PubMed ID: 30904214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched-chain amino acids in liver disease: new aspects of long known phenomena.
    Plauth M; Schütz T
    Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):61-6. PubMed ID: 21088568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.
    van Dijk AM; Bruins Slot AS; Portincasa P; Siegerink SN; Chargi N; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
    Eur J Clin Invest; 2023 Mar; 53(3):e13909. PubMed ID: 36394355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on branched-chain amino acid supplementation in liver diseases.
    Bianchi G; Marzocchi R; Agostini F; Marchesini G
    Curr Opin Gastroenterol; 2005 Mar; 21(2):197-200. PubMed ID: 15711213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.